ChristopherDittusDOMPH
Oncology • Chapel Hill, NCHematologic Oncology
Associate Professor of Medicine, Lymphoma Program
Dr. Dittus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 984-974-0000Fax+1 919-966-7772- Is this information wrong?
Summary
- I specialize in the diagnosis and management of all types of lymphoma, including B-cell non-Hodgkin lymphoma (NHL), T-cell NHL, Hodgkin lymphoma, central nervous system (CNS) lymphoma, and virus-associated lymphoma. I am particularly interested in rare lymphomas, including adult T-cell leukemia/lymphoma (ATLL), extranodal NK/T-cell lymphoma (ENKTCL), plasmablastic lymphoma, and lymphoplasmacytic lymphoma (Waldenstrom’s). I serve as the primary investigator for many lymphoma trials that are open at UNC. My primary research interest is to find effective treatments for rare or underserved lymphomas; I am the UNC site PI for the AIDS Malignancy Consortium and serves as the PI on several studies that are evaluating novel therapies in HIV-associated malignancies. I am also interested in writing investigator-initiated trials (IITs) that target underserved lymphoma subtypes. Most recently, I edited, and contributed to, a book entitled “Novel Therapeutics for Rare Lymphomas.”
Education & Training
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalChief Residency, Internal Medicine, 2012 - 2013- Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Internal Medicine, 2009 - 2012
NYIT College Of Osteopathic MedicineClass of 2009
The George Washington UniversityMPH, Epidemiology, 2002 - 2003- Binghamton UniversityBS, Biology, 1998 - 2002
Certifications & Licensure
NC State License 2016 - 2024
MA State License 2013 - 2016
NY State License 2012 - 2014- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies Start of enrollment: 2013 Jan 02
- Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Start of enrollment: 2015 Oct 21
- Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas Start of enrollment: 2018 Mar 16
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsAnti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30lymphoma: a phase 1 study.Natalie S Grover, George Hucks, Marcie L Riches, Anastasia Ivanova, Dominic T Moore, Thomas C Shea, Mary Beth Seegars, Paul M Armistead, Kimberly A Kasow, Anne W Beave...> ;The Lancet. Haematology. 2024 Mar 28
- The optimal management of relapsed and refractory Hodgkin lymphoma: post-brentuximab and checkpoint inhibitor failure.Grover, N., Dittus, C., Thakkar, A., Beaven, A.> ;Hematology. American Society of Hematology. Education Program. 2023 Dec 8
- 1 citationsPatient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomas.Nicholas P Tschernia, Hillary Heiling, Allison M Deal, Catherine Cheng, Caroline Babinec, Megan Gonzalez, J Kaitlin Morrison, Christopher Dittus, Gianpietro Dotti, Ann...> ;Journal for Immunotherapy of Cancer. 2023 Aug 1
- Join now to see all
Authored Content
- Novel Therapeutics for Rare LymphomasJanuary 2020
Press Mentions
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaAugust 15th, 2023
Dittus and colleagues write the book on rare lymphomasApril 21st, 2020
Professional Memberships
- Member
- Member
Hospital Affiliations
University of North Carolina HospitalsChapel Hill, North Carolina
External Links
- ResearchGatehttps://www.researchgate.net/profile/Christopher_Dittus
- UNC Faculty Pagehttps://unclineberger.org/directory/dittus/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
